Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?

PloS one - 1 Jan 2017

Niemelä Valter, Landtblom Anne-Marie, Blennow Kaj, Sundblom Jimmy

Abstract excerpt

INTRODUCTION: Previous studies have suggested cerebrospinal fluid (CSF) levels of neurofilament light (NFL) and total tau are elevated in Huntington's disease (HD) and may be used as markers of disease stage. Biomarkers are needed due to the slow disease progression and the limitations of clinical assessment. This study aims to validate the role of NFL and tau as biomarkers in HD. METHODS: CSF was obtained from a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Axons
Share to Biomarkers
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Enzyme-Linked Immunosorbent Assay

Share to Huntington Disease

Share to Neurofilament Proteins

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 28241046
DOI: 10.1371/journal.pone.0172762
PMCID: PMC5328385

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?PMID 28241046Read ↗

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisSemantic proximity Read ↗

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.Semantic proximity Read ↗

Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF studySemantic proximity Read ↗

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s diseaseSemantic proximity Read ↗

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studySemantic proximity Read ↗

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease ProgressionSemantic proximity Read ↗

Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson’s diseaseSemantic proximity Read ↗

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in ChildrenSemantic proximity Read ↗

Neurofilament light protein as a blood biomarker for Huntington’s disease in childrenSemantic proximity Read ↗

Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive ReviewSemantic proximity Read ↗

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.Semantic proximity Read ↗

Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.